Rosuvastatin for Reduction of Myocardial Damage and Systemic Inflammation During Coronary Angioplasty

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
Myocardial necrosis is relatively frequent after percutaneous coronary intervention and is associated with higher mortality during the follow-up. Since anti-inflammatory properties of statins have been demonstrated and the benefit of statins in acute coronary syndromes have been proven, this study aims at testing the hypothesis that the pre-procedural intensive statin treatment reduce the extent of peri-procedural necrosis.
Epistemonikos ID: d18a77f89b4a3748df75699731ea87bba266a00a
First added on: May 12, 2024